• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center
eNews, DF/HCC's online quarterly newsletter, highlights the groundbreaking research, news, and events taking place within DF/HCC, and showcases the services and tools DF/HCC offers to facilitate collaboration and discovery in the Harvard community.

Welcome to Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.

Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.

Latest Cancer News

    DF/HCC and Northeastern University work together to offer training opportunities in cancer nanomedicine

    August 19, 2014 Northeastern University has received a five-year, $1.15 million grant from the National Institute of Health’s National Cancer Institute to train the next... | [more]

    Sorensen awarded NCI funding to study tobacco cessation intervention in India

    Glorian Sorensen PhD, MPH (DFCI) was recently awarded $200,000 from the National Cancer Institute (NCI) to promote research collaborations with institutions in low-... | [more]

    NCI Center to Reduce Cancer Health Disparities Spotlights Center for Personalized Cancer Therapy

    UMass Boston and DF/HCC have a U54 Partnership grant with NCI/CRCHD to develop life sciences and CPCT on the UMass Boston campus. Read the Spotlight: ... | [more]